[1]
Charrois-Durand, C. , Saad, F., Barkati, M. , Lattouf , J.-B. , Perrotte, P. , Karakiewicz, P.I. , Soulières , D. , Blais, N. , Hamilou , Z. , Juneau, D. , Plouznikoff, N. , Taussky, D. and Delouya, G. 2022. A single-center, multidisciplinary experience with radium-223 dichloride in men with metastatic castrate-resistant prostate cancer. Canadian Urological Association Journal. 16, 6 (Jan. 2022), 199–205. DOI:https://doi.org/10.5489/cuaj.7591.